Tuesday 8 July, 2025 According to the Youth Endowment Fund’s Children, Violence and Vulnerability Report 5, children most vulnerable to…
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…